ContactForm

Our Intellectual Property.

The Brain has long been the Holy Grail of Human Knowledge and Scientific Interest.

At NURO, we decided early on that this quest was worth our complete dedication and relentless efforts to achieve breakthrough technological advances. In such journey, our team made sure that our work was documented and protected to ensure that our investment would be fruitful and rightfully ours.

Our firm takes matters of Intellectual Property extremely seriously and we work with some of the top law firms worldwide to guarantee that our commitment continues to deliver outstanding results for all.

If you have questions, are interested in licensing our technologies or believe your work might be conflicting with ours, we welcome healthy communications and win-win strategies.


For reference, NURO primarily works with these two global law firms for matters of IP licensing and enforcement:

NORTON ROSE FULBRIGHT LLP.

222 Bay Street, Suite 3000, Toronto, ON M5K 1E7

www.nortonrosefulbright.com

and

MINTZ LAW

200 Bay Street, South Tower, Suite 2800, Toronto, ON M5J 2J3

www.mintz.com

Our trademarks.

/imgs/trademarks/cipo.png
/imgs/trademarks/uspto.png
/imgs/trademarks/cipo.png
/imgs/trademarks/uspto.png
/imgs/trademarks/cipo.png
/imgs/trademarks/uspto.png
/imgs/trademarks/cipo.png
/imgs/trademarks/uspto.png

Our patents.

NURO CORP. is a Canadian corporation serving clients in various parts of the world and its products, services, systems or methodologies are protected by patent-pending applications and issued patents, including but not limited to the following:

Additional patents may be pending in Canada, the United States of America and other jurisdictions.

Accordingly, these innovations are safeguarded under a range of patent laws across multiple jurisdictions, including but not limited to 35 U.S.C. § 287(a), which requires patentees to provide public notice of their patent rights. Any unauthorized manufacturing, use, sale, or distribution of these proprietary products, services, systems or methodologies may constitute infringement under 35 U.S.C. § 271 or other applicable legal provisions.